Scotiabank lowered the firm’s price target on Illumina to $164 from $176 and keeps an Outperform rating on the shares. The company reported “mixed” Q2 results, with the firm lowering its 2024 and 2025 revenue estimates, the analyst tells investors. However, the firm still believes there is potential for the company to accelerate its top-line growth in the longer-term and its pipeline is still in an “unparalleled competitive position.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Starbucks, Chipotle upgraded: Wall Street’s top analyst calls
- Illumina upgraded to Equal Weight from Underweight at Barclays
- Illumina upgraded to Buy from Hold at TD Cowen
- Illumina poised to accelerate revenue growth into high single digits over 3 yrs
- Illumina price target lowered to $195 from $200 at Piper Sandler